McCormick & Company, Incorporated vs 10X Genomics Inc — how do they compare? McCormick & Company, Incorporated trades at $52.01 (market cap $14.04B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: McCormick & Company, Incorporated is far larger — about 2.6× 10X Genomics Inc's market cap, and McCormick & Company, Incorporated pays a 3.68% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| MKC | TXG | |
|---|---|---|
Market Cap | $14.04B | $5.48B |
Sector | Consumer Staples | Health |
52-Week High | $72.81 | $45.80 |
52-Week Low | $45.60 | $11.34 |
Enterprise Value | $18.65B | $5.02B |
Dividend Yield | 3.68% | — |
Trailing returns across standard periods
Latest headlines on both assets
In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →